T1	Participants 431 452	477 women with anemia
T2	Participants 796 843	more patients assigned to ferric carboxymaltose
T3	Participants 1143 1186	Patients treated with ferric carboxymaltose
T4	Participants 1415 1454	In patients with iron deficiency anemia
